Nektar Therapeutics
NKTR
NKTR
238 hedge funds and large institutions have $2.35B invested in Nektar Therapeutics in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 82 increasing their positions, 76 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
–
Holders Change %
0%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
42
Increased
82
Reduced
76
Closed
40
Calls
$33.8M
Puts
$24.5M
Net Calls
+$9.33M
Net Calls Change
-$11.2M
Top Buyers
| 1 |
1
BlackRock
New York
|
$360M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$250M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$498M |
| 4 |
WP
4
Woodline Partners
San Francisco,
California
|
$13.3M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$71.5M |
